EHMT1 binds to NF-κB p50 and represses gene expression. by Ea, C.K., Hao, S., Yeo, K.S., Baltimore, D.

Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission by Balazs AB, Chen J, Hong C, Ouyang S, An D, Baltimore D

HIV-1 conserved mosaics delivered by regimens with integration-deficient, DC-targeting lentiviral vector induce robust T cells by Hanke, T, Wee, E, Ondondo, B, Berglund, P, Archer, J, McMichael, A, Baltimore, D, ter Meulen, J

The challenges of an HIV vaccine enterprise - Response by Klausner, R, Fauci, A, Corey, L, Nabel, G, Gayle, H, Berkley, S, Haynes, B, Baltimore, D, Collins, C, Douglas, R, Esparza, J, Francis, D, Ganguly, N, Gerberding, J, Johnson, M, Kazatchkine, MD, Mcmichael, A, Makgoba, M, Pantaleo, G, Piot, P, Shao, Y, Tramont, E, Varmus, H, Wasserheit, J

Medicine. The need for a global HIV vaccine enterprise. by Klausner, R, Fauci, A, Corey, L, Nabel, G, Gayle, H, Berkley, S, Haynes, B, Baltimore, D, Collins, C, Douglas, R, Esparza, J, Francis, D, Ganguly, N, Gerberding, J, Johnston, M, Kazatchkine, MD, Mcmichael, A, Makgoba, M, Pantaleo, G, Piot, P, Shao, Y, Tramont, E, Varmus, H, Wasserheit, J

The Challenges of an HIV Vaccine Enterprise [2] (multiple letters) by Zinkernagel, R, Wolf, H, Klasner, R, Fauci, A, Corey, L, Nabel, G, Gayle, H, Berkley, S, Haynes, B, Baltimore, D, Collins, C, Douglas, R, Esparza, J, Francis, D, Ganguly, N, Gerberding, J, Johnson, M, Kazatchkine, MD, Mcmichael, A, Makgoba, M, Pantaleo, G, Piot, P, Shao, Y, Tramont, E, Varmus, H